Sep 29, 2026
uniQure (QURE) Stock Crashes 48% on Disappointing Huntington’s Trial Results
uniQure (QURE) stock plummeted 48% after AMT-130 gene therapy missed its statistical endpoint in new 48-month Huntington's disease trial data.
The post uniQure (QURE) Stock Crashes 48% on Disappointing Huntington’s Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 53 minutes ago
Rocket Lab (RKLB) Stock: Surges as Electron Completes 98th Launch for HawkEye 36...
- 3 hours ago
Cosmos (ATOM) Price Prediction: Can ATOM Reach $15?
- 3 hours ago
XRP News: Why Korea’s KYC-Ready Traders Could Fast-Track XRP Tokenization
- 6 hours ago
Robinhood sees surge in bitcoin, gold prediction markets as traders move beyond...
- 6 hours ago
Bitcoin Price Prediction: When Will BTC Hit $100K Again?